GENEVA, Aug. 7 -- MONTE ROSA THERAPEUTICS AG filed a patent application (EP2026/052202) for “DIOXOPIPERIDINE DERIVATIVES AS NEK7 DEGRADERS FOR USE IN THE TREATMENT OF WILSON DISEASE”. With publication no. WO/2026/162581, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/132
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....